NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

胎兒監測市場成長機會、成長預測 (2020-2027年):各產品、手法 (侵入性、非侵入性)、攜帶性 (可攜式、非可攜式)、用途 (分娩時胎兒監測、分娩前胎兒監測)、地區

Fetal Monitoring Market by Product, Method (Invasive and Non-Invasive), Portability (Portable and Non-Portable), Application (Intrapartum Fetal Monitoring and Antepartum Fetal Monitoring): Global Opportunity Analysis and Industry Forecast, 2020-2027

出版商 Allied Market Research 商品編碼 980754
出版日期 內容資訊 英文 214 Pages
商品交期: 2-3個工作天內
價格
胎兒監測市場成長機會、成長預測 (2020-2027年):各產品、手法 (侵入性、非侵入性)、攜帶性 (可攜式、非可攜式)、用途 (分娩時胎兒監測、分娩前胎兒監測)、地區 Fetal Monitoring Market by Product, Method (Invasive and Non-Invasive), Portability (Portable and Non-Portable), Application (Intrapartum Fetal Monitoring and Antepartum Fetal Monitoring): Global Opportunity Analysis and Industry Forecast, 2020-2027
出版日期: 2020年11月30日內容資訊: 英文 214 Pages
簡介

全球胎兒監測的市場規模在預測期間內預計以5.3%的年複合成長率發展,從2019年的29億3170萬美元,成長到2027年42億5110萬美元的規模。早產增加,出生率增加,技術的進步,妊娠中的胎兒監測的需求擴大,分娩前出血率的上升等要素促進該市場的成長。同時,設備的高成本性,嚴格的法規手續,尤其是幾個先進國家的出生率低等課題預計妨礙市場進一步成長。

本報告提供全球胎兒監測的市場調查,市場定義和概要,新型冠狀病毒感染疾病 (COVID-19) 以及其他的市場影響因素分析,市場規模的變化、預測,產品、攜帶、手法、用途、終端用戶、地區/主要國家等各種區分的明細,競爭環境,主要企業簡介等彙整資訊。

第1章 簡介

第2章 摘要整理

第3章 市場概要

  • 市場定義、調查範圍
  • 主要企業的地位
  • 波特的五力分析
  • 市場動態
    • 促進因素
    • 阻礙因素
    • 市場機會
    • 影響分析
  • COVID-19的影響

第4章 市場分析、預測:各產品

  • 概要
  • 超音波
    • 多普勒成像
  • 子宮內壓導管(IUPC)
  • 遙測解決方案
  • 電子胎兒監測(EFM)
    • 外部EFM
    • 內部EFM
  • 胎兒電極
  • 多普勒胎兒心率儀
  • 配件、消耗品
  • 其他
    • 主要趨勢、成長要素、市場機會
    • 市場規模、預測:各地區

第5章 市場分析、預測:各攜帶性

  • 概要
  • 非可攜式
  • 可攜式
    • 市場規模、預測

第6章 市場分析、預測:各手法

  • 概要
  • 非侵入性
  • 侵入性
    • 市場規模、預測

第7章 市場分析、預測:各用途

  • 概要
  • 分娩前胎兒監測
  • 分娩時胎兒監測
    • 市場規模、預測

第8章 市場分析、預測:各終端用戶

  • 概要
  • 醫院
  • 診所
  • 其他
    • 市場規模、預測

第9章 市場分析、預測:各地區、主要國家

  • 概要
  • 北美
  • 歐洲
  • 亞太地區
  • 南美、中東、非洲
    • 主要趨勢、成長要素、市場機會
    • 市場規模、預測:各國
    • 市場規模、預測:各產品
    • 市場規模、預測:各攜帶性
    • 市場規模、預測:各手法
    • 市場規模、預測:各用途
    • 市場規模、預測:各終端用戶

第10章 企業簡介

  • Analogic Corporation
  • Cardinal Health
  • FUJIFILM Holdings Corporation
  • GENERAL ELECTRIC
  • Getinge AB
  • Koninklijke Philips N.V. (Philips Healthcare)
  • Natus Medical Incorporated
  • Neoventa Medical AB
  • OSI Systems, Inc.
  • SIEMENS AG (Siemens Healthineers)
目錄
Product Code: A01560

Title:
Fetal Monitoring Market by Product {Ultrasound (2D, 3D & 4D, and Doppler Imaging), Intrauterine Pressure Catheter (IUPC), Telemetry Solutions, Electronic Fetal Monitoring (EFM) (External & Internal), Fetal Electrodes, Fetal Doppler, Accessories & Consumables, and Other Products}, Method (Invasive and Non-Invasive), Portability (Portable and Non-Portable), Application (Intrapartum Fetal Monitoring and Antepartum Fetal Monitoring): Global Opportunity Analysis and Industry Forecast, 2020-2027.

The global fetal monitoring market accounted for $2,931.7 million in 2019 and is expected to reach $4,251.1 million by 2027, registering a CAGR of 5.3% from 2020 to 2027.

Fetal monitoring is vital diagnostic tool used to monitor movement and heart rate of a fetus and maternal contractions. It is a fundamental device used for monitoring uterine contractions during labor. It mainly monitors well-being of fetus and progress of labor. In medical terms, it is referred as medical method to check health of an unborn baby to ensure a safe birth. In addition, it is also used to monitor chronic lung diseases, mental retardation, neonatal diseases, hypothermia, vision & hearing problems, jaundice, and neonatal diseases.

Increase in preterm births & birth rates, rise in technological advancements, increase in need for fetal monitoring during pregnancy, rise in antepartum hemorrhage rate, and premature delivery rate drive the global fetal monitoring market. However, high cost of equipment, stringent regulatory procedures, and low prevalence of birth rates, especially in few developed countries impede the market growth. Further, emerging technologies, such as portable & wireless products and untapped emerging economies offer lucrative opportunities for the market players.

The global fetal monitoring market is segmented on the basis of product, method, portability, application, and geography. By product, it is divided into ultrasound, intrauterine pressure catheter (IUPC), telemetry solutions, electronic fetal monitoring (EFM), fetal electrodes, fetal doppler, accessories, consumables, and other products.

The ultrasound product segment held the largest market share in 2019, owing to technological advancements and a wide array of applications. By method, the market is bifurcated into non-invasive and invasive fetal monitoring methods. The non-invasive method held the highest market share in 2019, owing to advancements in fetal monitoring methods. By application, it is categorized into antepartum fetal monitoring and intrapartum fetal monitoring applications. The antepartum fetal monitoring application was the highest revenue contributor in 2019, while the intrapartum fetal monitoring segment is anticipated to grow at the highest rate. Growth of the intrapartum application segment is high as these applications are mostly carried out during second and third trimesters of pregnancy. This application also reduces the incidences of stillbirths by routinely assessing the risk of fetal death in complicated pregnancies with preexisting maternal conditions such as diabetes mellitus.

Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America accounted for the largest market share in 2019, and is expected to retain its dominance throughout the forecast period. This is attributed to factors such as well-equipped and better financed hospitals & clinics, high adoption rate for technologically advanced products, and sophisticated healthcare infrastructure. Moreover, the U.S. is the target area for top players in the market, owing to high awareness about fetal monitoring. However, Asia-Pacific is expected to emerge as a lucrative area with maximum growth potential, owing to improvement in healthcare facilities, available disposable income, and rapidly developing economic conditions.

The key players operating in the global fetal monitoring market include GE Healthcare, Analogic Corporation, Fujifilm Sonosite, Inc., Koninklijke Philips N.V., Siemens Healthcare, Medtronic Plc, Getinge Group, Neoventa Medical AB, Natus Medical Incorporated, and OSI Systems, Inc.

KEY BENEFITS FOR STAKEHOLDERS

The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.

It offers a quantitative analysis from 2019 to 2027, which is expected to enable stakeholders to capitalize on prevailing market opportunities.

A comprehensive analysis of the countries in North America, Europe, Asia-Pacific, and LAMEA is provided to determine the existing opportunities.

The key market players and their strategies have been analyzed to understand the competitive outlook of the market.

KEY MARKET SEGMENTS

By Product

  • Ultrasound
  • 2D Ultrasound
  • 3D & 4D Ultrasound
  • Doppler Imaging
  • Intrauterine Pressure Catheter (IUPC)
  • Telemetry Solutions
  • Electronic Fetal Monitoring (EFM)
  • External EFM
  • Internal EFM
  • Fetal Electrodes
  • Fetal Doppler
  • Accessories & Consumables
  • Other Products

By Method

  • Invasive
  • Non-Invasive

By Portability

  • Portable
  • Non-Portability

By Application

  • Intrapartum Fetal Monitoring
  • Antepartum Fetal Monitoring

By End User

  • Hospitals
  • Clinics
  • Others

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Turkey
  • Rest of LAMEA

LIST OF KEY PLAYERS PROFILED IN THE REPORT

  • GE Healthcare
  • Analogic Corporation
  • Fujifilm Sonosite, Inc.
  • Koninklijke Philips N.V.
  • Siemens Healthcare
  • Medtronic Plc
  • Getinge Group
  • Neoventa Medical AB
  • Natus Medical Incorporated
  • OSI Systems, Inc.

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

  • 1.1.Report description
  • 1.2.Key market segments
    • 1.2.1.List of key players profiled in the report
  • 1.3.Research methodology
    • 1.3.1.Primary research
    • 1.3.2.Secondary research
    • 1.3.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

  • 2.1.Key findings of the study
  • 2.2.CXO perspective

CHAPTER 3:MARKET OVERVIEW

  • 3.1.Market definition and scope
  • 3.2.Top player positioning
    • 3.2.1.Top investment pockets
  • 3.3.Key forces shaping fetal monitoring industry/market
  • 3.4.Market dynamics
    • 3.4.1.Drivers
      • 3.4.1.1.Increase in preterm births
      • 3.4.1.2.Perpetual need for fetal monitoring
      • 3.4.1.3.Active government and non-government initiatives
      • 3.4.1.4.Technological advancements
    • 3.4.2.Restraints
      • 3.4.2.1.Stringent regulatory procedures
      • 3.4.2.2.High cost associated with fetal monitoring devices
      • 3.4.2.3.Prevalence of declining birth rates
    • 3.4.3.Opportunity
      • 3.4.3.1.Lucrative opportunities in developing countries
      • 3.4.3.2.Portable and wireless products
    • 3.4.4.Impact Analysis
  • 3.1.Impact analysis of COVID-19 on the fetal monitoring market
    • 3.1.1.Overview
    • 3.1.2.Impact of COVID-19 on fetal monitoring market

CHAPTER 4:FETAL MONITORING MARKET, BY PRODUCT

  • 4.1.Overview
    • 4.1.1.Market size and forecast
  • 4.2.Ultrasound
    • 4.2.1.Key market trends, growth factors, and opportunities
    • 4.2.2.Ultrasound, By type
      • 4.2.2.1.Market size and forecast
      • 4.2.2.2.2D Ultrasound
      • 4.2.2.2.1.Market size and forecast
      • 4.2.2.3.3D & 4D Ultrasound
      • 4.2.2.3.1.Market size and forecast
      • 4.2.2.4.Doppler Imaging
      • 4.2.2.4.1.Market size and forecast
  • 4.3.INTRAUTERINE PRESSURE CATHETER (IUPC)
    • 4.3.1.Key market trends, growth factors, and opportunities
    • 4.3.2.Market size and forecast, by region
  • 4.4.TELEMETRY SOLUTIONS
    • 4.4.1.Key market trends, growth factors, and opportunities
    • 4.4.2.Market size and forecast, by region
  • 4.5.ELECTRONIC FETAL MONITORING (EFM)
    • 4.5.1.Key market trends, growth factors, and opportunities
    • 4.5.2.Market size and forecast, by region
      • 4.5.2.1.Market size and forecast
      • 4.5.2.2.External EFM
      • 4.5.2.2.1.Market size and forecast
      • 4.5.2.3.Internal EFM
      • 4.5.2.3.1.Market size and forecast
  • 4.6.FETAL ELECTRODES
    • 4.6.1.Key market trends, growth factors, and opportunities
    • 4.6.2.Market size and forecast, by region
  • 4.7.FETAL DOPPLER
    • 4.7.1.Key market trends, growth factors, and opportunities
    • 4.7.2.Market size and forecast, by region
  • 4.8.ACCESORIES AND CONSUMABLES
    • 4.8.1.Key market trends, growth factors, and opportunities
    • 4.8.2.Market size and forecast, by region
  • 4.9.OTHER FETAL MONITORING DEVICES
    • 4.9.1.Key market trends, growth factors, and opportunities
    • 4.9.2.Market size and forecast, by region

CHAPTER 5:FETAL MONITORING MARKET, BY PORTABILITY

  • 5.1.Overview
    • 5.1.1.Market size and forecast
  • 5.2.Non-Portable
    • 5.2.1.Market size and forecast
  • 5.3.Portable
    • 5.3.1.Market size and forecast

CHAPTER 6:FETAL MONITORING MARKET, BY METHOD

  • 6.1.Overview
    • 6.1.1.Market size and forecast
  • 6.2.Non-Invasive Method
    • 6.2.1.Market size and forecast
  • 6.3.Invasive Method
    • 6.3.1.Market size and forecast

CHAPTER 7:FETAL MONITORING MARKET, BY APPLICATION

  • 7.1.Overview
    • 7.1.1.Market size and forecast
  • 7.2.Antepartum Fetal Monitoring
    • 7.2.1.Market size and forecast
  • 7.3.Intrapartum Fetal Monitoring
    • 7.3.1.Market size and forecast

CHAPTER 8:FETAL MONITORING MARKET, BY END USER

  • 8.1.Overview
    • 8.1.1.Market size and forecast
  • 8.2.Hospitals
    • 8.2.1.Market size and forecast
  • 8.3.Clinics
    • 8.3.1.Market size and forecast
  • 8.4.Others
    • 8.4.1.Market size and forecast

CHAPTER 9:FETAL MONITORING MARKET, BY REGION

  • 9.1.Overview

Market size and forecast

  • 9.2.North America
    • 9.2.1.Key market trends, growth factors, and opportunities
    • 9.2.2.Market size and forecast, by country
    • 9.2.3.Market size and forecast, by product
    • 9.2.4.Market size and forecast, by portability
    • 9.2.5.Market size and forecast, by method
    • 9.2.6.Market size and forecast, by application
    • 9.2.7.Market size and forecast, by end user
      • 9.2.7.1.U.S. Market size and Forecast
      • 9.2.7.2.Canada market size and forecast
      • 9.2.7.3.Mexico
  • 9.3.Europe
    • 9.3.1.Key market trends, growth factors, and opportunities
    • 9.3.2.Market size and forecast, by country
    • 9.3.3.Market size and forecast, by product
    • 9.3.4.Market size and forecast, by portability
    • 9.3.5.Market size and forecast, by method
    • 9.3.6.Market size and forecast, by application
    • 9.3.7.Market size and forecast, by end user
      • 9.3.7.1.Germany market size and forecast
      • 9.3.7.2.France market size and forecast
      • 9.3.7.3.UK, market size and forecast
      • 9.3.7.4.Italy market size and forecast
      • 9.3.7.5.Spain market size and forecast
      • 9.3.7.6.Rest of Europe market size and forecast
  • 9.4.Asia-Pacific
    • 9.4.1.Key market trends, growth factors, and opportunities
    • 9.4.2.Market size and forecast, by country
    • 9.4.3.Market size and forecast, by product
    • 9.4.4.Market size and forecast, by portability
    • 9.4.5.Market size and forecast, by method
    • 9.4.6.Market size and forecast, by application
    • 9.4.7.Market size and forecast, by end user
      • 9.4.7.1.Japan market size and forecast
      • 9.4.7.2.China market size and forecast
      • 9.4.7.3.India, market size and forecast
      • 9.4.7.4.Australia market size and forecast
      • 9.4.7.5.Rest of Asia-Pacific, market size and forecast
  • 9.5.LAMEA
    • 9.5.1.Key market trends, growth factors, and opportunities
    • 9.5.2.Market size and forecast, by country
    • 9.5.3.Market size and forecast, by product
    • 9.5.4.Market size and forecast, by portability
    • 9.5.5.Market size and forecast, by method
    • 9.5.6.Market size and forecast, by application
    • 9.5.7.Market size and forecast, by end user
      • 9.5.7.1.Brazil
      • 9.5.7.2.South Africa market size and forecast
      • 9.5.7.3.Saudi Arabia
      • 9.5.7.4.Turkey
      • 9.5.7.5.Rest of LAMEA

CHAPTER 10:COMPANY PROFILES

  • 10.1.Analogic Corporation
    • 10.1.1.Company overview
    • 10.1.2.Company snapshot
    • 10.1.3.Operating business segments
    • 10.1.4.Product portfolio
    • 10.1.5.Business performance
  • 10.2.Cardinal Health
    • 10.2.1.Company overview
    • 10.2.2.Company snapshot
    • 10.2.3.Operating business segments
    • 10.2.4.Product portfolio
    • 10.2.5.Business performance
  • 10.3.FUJIFILM Holdings Corporation
    • 10.3.1.Company overview
    • 10.3.2.Company snapshot
    • 10.3.3.Operating business segments
    • 10.3.4.Product portfolio
    • 10.3.5.Business performance
  • 10.4.GENERAL ELECTRIC
    • 10.4.1.Company overview
    • 10.4.2.Company snapshot
    • 10.4.3.Operating business segments
    • 10.4.4.Product portfolio
    • 10.4.5.Business performance
    • 10.4.6.Key strategic moves and developments
  • 10.5.Getinge AB
    • 10.5.1.Company overview
    • 10.5.2.Company snapshot
    • 10.5.3.Operating business segments
    • 10.5.4.Product portfolio
    • 10.5.5.Business performance
  • 10.6.Koninklijke Philips N.V. (Philips Healthcare)
    • 10.6.1.Company overview
    • 10.6.2.Company snapshot
    • 10.6.3.Operating business segments
    • 10.6.4.Product portfolio
    • 10.6.5.Business performance
    • 10.6.6.Key strategic moves and developments
  • 10.7.Natus Medical Incorporated
    • 10.7.1.Company overview
    • 10.7.2.Company snapshot
    • 10.7.3.Operating business segments
    • 10.7.4.Product portfolio
    • 10.7.5.Business performance
  • 10.8.Neoventa Medical AB
    • 10.8.1.Company overview
    • 10.8.2.Company snapshot
    • 10.8.3.Operating business segments
    • 10.8.4.Product portfolio
    • 10.8.5.Key strategic moves and developments
  • 10.9.OSI Systems, Inc.
    • 10.9.1.Company overview
    • 10.9.2.Company snapshot
    • 10.9.3.Operating business segments
    • 10.9.4.Product portfolio
    • 10.9.5.Business performance
  • 10.10.SIEMENS AG (Siemens Healthineers)
    • 10.10.1.Company overview
    • 10.10.2.Company snapshot
    • 10.10.3.Operating business segments
    • 10.10.4.Product portfolio
    • 10.10.5.Business performance

LIST OF TABLES

  • TABLE 01.GLOBAL FETAL MONITORING MARKET, BY PRODUCT, 2019-2027 ($MILLION)
  • TABLE 02.ULTRASOUND MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 03.FETAL MONITORING MARKET FOR INTRAUTERINE PRESSURE CATHETER (IUPC), BY REGION, 2019-2027 ($MILLION)
  • TABLE 04.FETAL MONITORING MARKET FOR TELEMETRY SOLUTIONS, BY REGION, 2019-2027 ($MILLION)
  • TABLE 05.ELECTRONIC FETAL MONITORING, BY REGION, 2019-2027 ($MILLION)
  • TABLE 06.ELECTRONIC FETAL MONITORING MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 07.FETAL MONITORING MARKET FOR FETAL ELECTRODE, BY REGION, 2019-2027 ($MILLION)
  • TABLE 08.FETAL DOPPLER MARKET, BY REGION, 2019-2027 ($MILLION)
  • TABLE 09.ACCESSORIES AND CONSUMABLES MARKET FOR OBTURATOR, BY REGION, 2019-2027 ($MILLION)
  • TABLE 10.FETAL MONITORING MARKET FOR OTHER FETAL MONITORING DEVICES, BY REGION, 2019-2027 ($MILLION)
  • TABLE 11.FETAL MONITORING MARKET, BY PORTABILITY, 2019-2027 ($MILLION)
  • TABLE 12.FETAL MONITORING MARKET FOR NON-PORTABLE, BY REGION, 2019-2027 ($MILLION)
  • TABLE 13.FETAL MONITORING MARKET FOR PORTABLE, BY REGION, 2019-2027 ($MILLION)
  • TABLE 14.FETAL MONITORING MARKET, BY METHOD, 2019-2027 ($MILLION)
  • TABLE 15.FETAL MONITORING MARKET FOR NON-INVASIVE METHOD, BY REGION, 2019-2027 ($MILLION)
  • TABLE 16.FETAL MONITORING MARKET FOR INVASIVE METHOD, BY REGION, 2019-2027 ($MILLION)
  • TABLE 17.FETAL MONITORING MARKET, BY APPLICATION, 2019-2027 ($MILLION)
  • TABLE 18.FETAL MONITORING MARKET FOR ANTEPARTUM FETAL MONITORING, BY REGION, 2019-2027 ($MILLION)
  • TABLE 19.FETAL MONITORING MARKET FOR INTRAPARTUM FETAL MONITORING, BY REGION, 2019-2027 ($MILLION)
  • TABLE 20.FETAL MONITORING MARKET, BY END USER, 2019-2027 ($MILLION)
  • TABLE 21.FETAL MONITORING MARKET FOR HOSPITALS, BY REGION, 2019-2027 ($MILLION)
  • TABLE 22.FETAL MONITORING MARKET FOR CLINICS, BY REGION, 2019-2027 ($MILLION)
  • TABLE 23.FETAL MONITORING MARKET FOR OTHERS, BY REGION, 2019-2027 ($MILLION)
  • TABLE 24.FETAL MONITORING MARKET, BY REGION, 2019-2027 ($MILLION)
  • TABLE 25.NORTH AMERICA FETAL MONITORING MARKET, BY COUNTRY, 2019-2027 ($MILLION)
  • TABLE 26.NORTH AMERICA FETAL MONITORING MARKET, BY PRODUCT, 2019-2027 ($MILLION)
  • TABLE 27.NORTH AMERICA FETAL MONITORING MARKET, BY PORTABILITY, 2019-2027 ($MILLION)
  • TABLE 28.NORTH AMERICA FETAL MONITORING MARKET, BY METHOD, 2019-2027 ($MILLION)
  • TABLE 29.NORTH AMERICA FETAL MONITORING MARKET, BY APPLICATION, 2019-2027 ($MILLION)
  • TABLE 30.NORTH AMERICA FETAL MONITORING MARKET, BY END USER, 2019-2027 ($MILLION)
  • TABLE 31.EUROPE FETAL MONITORING MARKET, BY COUNTRY, 2019-2027 ($MILLION)
  • TABLE 32.EUROPE FETAL MONITORING MARKET, BY PRODUCT, 2019-2027 ($MILLION)
  • TABLE 33.EUROPE FETAL MONITORING MARKET, BY PORTABILITY, 2019-2027 ($MILLION)
  • TABLE 34.EUROPE FETAL MONITORING MARKET, BY METHOD, 2019-2027 ($MILLION)
  • TABLE 35.EUROPE FETAL MONITORING MARKET, BY APPLICATION, 2019-2027 ($MILLION)
  • TABLE 36.EUROPE FETAL MONITORING MARKET, BY END USER, 2019-2027 ($MILLION)
  • TABLE 37.ASIA-PACIFIC FETAL MONITORING MARKET, BY COUNTRY, 2019-2027 ($MILLION)
  • TABLE 38.ASIA-PACIFIC FETAL MONITORING MARKET, BY PRODUCT, 2019-2027 ($MILLION)
  • TABLE 39.ASIA-PACIFIC FETAL MONITORING MARKET, BY PORTABILITY, 2019-2027 ($MILLION)
  • TABLE 40.ASIA-PACIFIC FETAL MONITORING MARKET, BY METHOD, 2019-2027 ($MILLION)
  • TABLE 41.ASIA-PACIFIC FETAL MONITORING MARKET, BY APPLICATION, 2019-2027 ($MILLION)
  • TABLE 42.ASIA-PACIFIC FETAL MONITORING MARKET, BY END USER, 2019-2027 ($MILLION)
  • TABLE 43.LAMEA FETAL MONITORING MARKET, BY COUNTRY, 2019-2027 ($MILLION)
  • TABLE 44.LAMEA FETAL MONITORING MARKET, BY PRODUCT, 2019-2027 ($MILLION)
  • TABLE 45.LAMEA FETAL MONITORING MARKET, BY PORTABILITY, 2019-2027 ($MILLION)
  • TABLE 46.LAMEA FETAL MONITORING MARKET, BY METHOD, 2019-2027 ($MILLION)
  • TABLE 47.LAMEA FETAL MONITORING MARKET, BY APPLICATION, 2019-2027 ($MILLION)
  • TABLE 48.LAMEA FETAL MONITORING MARKET, BY END USER, 2019-2027 ($MILLION)
  • TABLE 49.ANALOGIC: COMPANY SNAPSHOT
  • TABLE 50.ANALOGIC: OPERATING SEGMENTS
  • TABLE 51.ANALOGIC:PRODUCT PORTFOLIO
  • TABLE 52.CARDINAL HEALTH: COMPANY SNAPSHOT
  • TABLE 53.CARDINAL HEALTH: OPERATING SEGMENTS
  • TABLE 54.CARDINAL HEALTH: PRODUCT PORTFOLIO
  • TABLE 55.FUJIFILM: COMPANY SNAPSHOT
  • TABLE 56.FUJIFILM HOLDINGS CORPORATION: PRODUCT SEGMENTS
  • TABLE 57.FUJIFILM: PRODUCT PORTFOLIO
  • TABLE 58.GE.: COMPANY SNAPSHOT
  • TABLE 59.GE.: OPERATING SEGMENTS
  • TABLE 60.GE: PRODUCT PORTFOLIO
  • TABLE 61.GETINGE: COMPANY SNAPSHOT
  • TABLE 62.GETINGE: OPERATING SEGMENTS
  • TABLE 63.GETINGE: PRODUCT PORTFOLIO:
  • TABLE 64.PHILIPS: COMPANY SNAPSHOT
  • TABLE 65.PHILIPS: OPERATING SEGMENTS
  • TABLE 66.PHILIPS: PRODUCT PORTFOLIO
  • TABLE 67.NATUS: COMPANY SNAPSHOT
  • TABLE 68.NATUS: OPERATING SEGMENTS
  • TABLE 69.NATUS: PRODUCT PORTFOLIO
  • TABLE 70.NEOVENTA: COMPANY SNAPSHOT
  • TABLE 71.NEOVENTA: OPERATING SEGMENTS
  • TABLE 72.NEOVENTA: PRODUCT PORTFOLIO
  • TABLE 73.OSI: COMPANY SNAPSHOT
  • TABLE 74.OSI: OPERATING SEGMENTS
  • TABLE 75.OSI: PRODUCT PORTFOLIO
  • TABLE 76.SIEMENS: COMPANY SNAPSHOT
  • TABLE 77.SIEMENS: OPERATING SEGMENTS
  • TABLE 78.SIEMENS: PRODUCT PORTFOLIO

LIST OF FIGURES

  • FIGURE 01.GLOBAL FETAL MONITORING MARKET SEGMENTATION
  • FIGURE 02.TOP PLAYER POSITIONING, 2019
  • FIGURE 03.TOP INVESTMENT POCKETS
  • FIGURE 04.MODERATE BARGAINING POWER OF SUPPLIER
  • FIGURE 05.MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 06.MODERATE THREAT OF SUBSTITUTES
  • FIGURE 07.MODERATE INTENSITY OF RIVALRY
  • FIGURE 08.HIGH THREAT OF NEW ENTRANT
  • FIGURE 09.IMPACT ANALYSES, FETAL MONITORING MARKET
  • FIGURE 10.FETAL MONITORING MARKET FOR 2D ULTRASOUND MARKET, 2019-2027 ($MILLION)
  • FIGURE 11.FETAL MONITORING MARKET FOR 3D & 4D ULTRASOUND MARKET, 2019-2027 ($MILLION)
  • FIGURE 12.FETAL MONITORING MARKET FOR DOPPLER IMAGING, 2019-2027 ($MILLION)
  • FIGURE 13.FETAL MONITORING MARKET, 2020-2027 ($MILLION)
  • FIGURE 14.FETAL MONITORING MARKET, 2019-2027 ($MILLION)
  • FIGURE 15.U.S.FETAL MONITORING MARKET, 2019-2027 ($MILLION)
  • FIGURE 16.CANADA FETAL MONITORING MARKET, 2019-2027 ($MILLION)
  • FIGURE 17.MEXICO FETAL MONITORING MARKET, 2019-2027 ($MILLION)
  • FIGURE 18.GERMANY FETAL MONITORING MARKET, 2019-2027 ($MILLION)
  • FIGURE 19.FRANCE FETAL MONITORING MARKET, 2019-2027 ($MILLION)
  • FIGURE 20.UK FETAL MONITORING MARKET, 2019-2027 ($MILLION)
  • FIGURE 21.ITALY FETAL MONITORING MARKET, 2019-2027 ($MILLION)
  • FIGURE 22.SPAIN FETAL MONITORING MARKET, 2019-2027 ($MILLION)
  • FIGURE 23.REST OF EUROPE FETAL MONITORING MARKET, 2019-2027 ($MILLION)
  • FIGURE 24.JAPAN FETAL MONITORING MARKET, 2019-2027 ($MILLION)
  • FIGURE 25.CHINA FETAL MONITORING MARKET, 2019-2027 ($MILLION)
  • FIGURE 26.INDIA FETAL MONITORING MARKET, 2019-2027 ($MILLION)
  • FIGURE 27.AUSTRALIA FETAL MONITORING MARKET, 2019-2027 ($MILLION)
  • FIGURE 28.REST OF ASIA-PACIFIC FETAL MONITORING MARKET, 2019-2027 ($MILLION)
  • FIGURE 29.BRAZIL FETAL MONITORING MARKET, 2019-2027 ($MILLION)
  • FIGURE 30.SOUTH AFRICA FETAL MONITORING MARKET, 2019-2027 ($MILLION)
  • FIGURE 31.SAUDI ARABIA FETAL MONITORING MARKET, 2019-2027 ($MILLION)
  • FIGURE 32.TURKEY FETAL MONITORING MARKET, 2019-2027 ($MILLION)
  • FIGURE 33.REST OF LAMEA FETAL MONITORING MARKET, 2019-2027 ($MILLION)
  • FIGURE 34.ANALOGIC: NET SALES, 2015-2017 ($MILLION)
  • FIGURE 35.ANALOGIC: REVENUE SHARE, BY SEGMENT, 2017(%)
  • FIGURE 36.ANALOGIC: REVENUE SHARE, BY REGION, 2017(%)
  • FIGURE 37.CARDINAL HEALTH: NET SALES, 2017-2019 ($MILLION)
  • FIGURE 38.CARDINAL HEALTH: REVENUE SHARE, BY SEGMENT, 2019 (%)
  • FIGURE 39.CARDINAL HEALTH: REVENUE SHARE, BY REGION, 2019(%)
  • FIGURE 40.FUJIFILM: NET SALES, 2016-2018 ($MILLION)
  • FIGURE 41.FUJIFILM: REVENUE SHARE, BY SEGMENT, 2018 (%)
  • FIGURE 42.GE: NET SALES, 2016-2018 ($MILLION)
  • FIGURE 43.GE: REVENUE SHARE, BY SEGMENT, 2018(%)
  • FIGURE 44.GE: REVENUE SHARE, BY REGION, 2018(%)
  • FIGURE 45.GETINGE: NET SALES, 2016-2018 ($MILLION)
  • FIGURE 46.GETINGE: REVENUE SHARE, BY SEGMENTS, 2018 (%)
  • FIGURE 47.GETINGE: REVENUE SHARE, BY REGION, 2018 (%)
  • FIGURE 48.PHILIPS: NET SALES, 2017-2018 ($MILLION)
  • FIGURE 49.PHILIPS REVENUE SHARE, BY SEGMENTS, 2018 (%)
  • FIGURE 50.PHILIPS: REVENUE SHARE, BY REGIONS, 2018 (%)
  • FIGURE 51.NATUS: NET SALES, 2016-2018 ($MILLION)
  • FIGURE 52.NATUS: REVENUE SHARE, BY SEGMENT, 2018(%)
  • FIGURE 53.NATUS: REVENUE SHARE, BY REGION, 2018(%)
  • FIGURE 54.OSI SYSTEMS, INC.: NET SALES, 2017-2019 ($MILLION)
  • FIGURE 55.OSI: REVENUE SHARE, BY SEGMENTS, 2019 (%)
  • FIGURE 56.OSI: REVENUE SHARE, BY REGION, 2019 (%)
  • FIGURE 57.NET SALES, 2016-2018 ($MILLION)
  • FIGURE 58.SIEMENS: REVENUE SHARE, BY SEGMENT, 2018 (%)
  • FIGURE 59.SIEMENS: REVENUE SHARE, BY REGION, 2018 (%)